# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company foc...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
Organovo released the complete details of its 16-week, randomized, placebo-controlled, multi-center Phase 2 study of the non-st...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...
GS: 4.5% | Goldman Sachs shares are trading higher after the company reported better-than-expected Q1 EPS and revenues. LGVN: ...